Faculty, Staff and Student Publications
Open-access journal articles from UTHealth GSBS faculty, staff and students.
Submissions from 2025
Mutation of Conserved Mhc Class I Cytoplasmic Tyrosine Affects CD8+ T Cell Priming, Effector Function, and Memory Response, Yimo Sun, Yitao Tang, Priscilla Ortiz, et al.
Differentiation Stage Predicts Radiosensitivity in Mesenchymal-Like Pancreatic Cancer, Tingshi Su, Xinjian Yu, Mojtaba Hoseini-Ghahfarokhi, et al.
VEN in Combination With 10-Day DEC in Newly Diagnosed Elderly or Relapsed/Refractory Acute Myeloid Leukemia, and High-Risk Myelodysplastic Syndrome: Long Term Follow-Up of a Phase 2 Trial, Mahesh Swaminathan, Courtney D DiNardo, Abhishek Maiti, et al.
Circulating Tumor DNA Monitoring and Blood Tumor Mutational Burden in Patients With Metastatic Solid Tumors Treated With Atezolizumab, Charles Swanton, Russell W Madison, Candice Francheska B Tambaoan, et al.
Provider Attitudes and Perspectives on Rehabilitation for Pediatric Cancer Patients, Maria C Swartz, Eduardo Gonzalez Villarreal, Keri Schadler, et al.
Early Treatment Discontinuation in Patients With Deficient Mismatch Repair or Microsatellite Instability High Metastatic Colorectal Cancer Receiving Immune Checkpoint Inhibitors, Julien Taieb, Margherita Ambrosini, Emily Alouani, et al.
RNA Sculpting by the Primordial Helix-Clasp-Helix-Strand-Loop (HcH-SL) Motif Enforces Chemical Recognition Enabling Diverse KH Domain Functions, John A Tainer and Susan E Tsutakawa
Sequence of Therapy Impact on Older Women With Comorbidities and Triple-Negative or HER2-Positive Breast Cancer, Nina Tamirisa, Wenli Dong, Yu Shen, et al.
A Serum Biomarker Panel and Miniarray Detection System for Tracking Disease Activity and Flare Risk in Lupus Nephritis, Chenling Tang, Gongjun Tan, Aygun Teymur, et al.
Experimental Design and Control Methods for Dose Rate Optimization in a Synchrotron-Based Proton Therapy Beamline, Jason Tang, Daniel Liu, Jacob Mathew, et al.
Allosteric Targeted Drug Delivery for Enhanced Blood-Brain Barrier Penetration via Mimicking Transmembrane Domain Interactions, Kaicheng Tang, Zhongjie Tang, Miaomiao Niu, et al.
USP37 Counteracts HLTF To Protect Damaged Replication Forks and Promote Survival of BRCA1-Deficient Cells and PARP Inhibitor Resistance, Mengfan Tang, Siting Li, Ziqiang Zhu, et al.
Sexually Dimorphic Sail Feathers in the Mandarin Duck as a Model for Lifelong Developmental Modulation, Pin-Chi Tang, Hsu-Chen Cheng, Gee-Way Lin, et al.
The Impact of Targeting TRAF2 and NCK-Interacting Protein Kinase on Antitumor Effect and Tumor Immune Environment in c-MYC-High SCLC, Azusa Tanimoto, Kavya Ramkumar, C Allison Stewart, et al.
The Impact of a Small-Group Mammography Video Discussion on Promoting Screening Uptake Among Nonadherent Chinese American Immigrant Women: A Randomized Controlled Trial, Naomi Q P Tan, Grace X Ma, Annette E Maxwell, et al.
Revisiting Phosphoregulation of Cdc25C During M-phase Induction, Tan Tan, Chuanfen Wu, Ruoning Wang, et al.
Pharmacological Profiling in Cll Patients During Pirtobrutinib Therapy and Disease Progression, Shady I Tantawy, Burcu Aslan, Ganiraju Manyam, et al.
Quantitative Proteomics Identifies Conserved Proteins and Altered Regulation of Mucin-16 in Low Grade Serous Ovarian Cancers, Christopher M Tarney, Paulette Mhawech-Fauceglia, Jonathan D Ogata, et al.
Society for Immunotherapy of Cancer: Updates and Best Practices for Multiplex Immunohistochemistry (Ihc) and Immunofluorescence (if) Image Analysis and Data Sharing, Janis M Taube, Joel C Sunshine, Michael Angelo, et al.
Reference Dosimetry Data and Machine Performance Comparison for Tomotherapy Delivery Systems Audited by IROC, Paige A Taylor, Hunter Mehrens, Mallory C Glenn, et al.
Plant-Nanoparticles Enhance Anti-Pd-L1 Efficacy by Shaping Human Commensal Microbiota Metabolites, Yun Teng, Chao Luo, Xiaolan Qiu, et al.
Probabilistic Template Matching for Detecting Resting-State Functional MRI Language Network in Brain Tumor Patients, Jian Ming Teo, Vinodh A Kumar, Alexander M Khalaf, et al.
Therapeutic Targeting of Syndecan-1 Axis Overcomes Acquired Resistance to Kras-Targeted Therapy in Gastrointestinal Cancers, Madelaine S Theardy, Mitsunobu Takeda, Alexey Sorokin, et al.
Correction to: Selinexor in Combination With Carboplatin and Paclitaxel in Patients With Advanced Solid Tumors: Results of a Single-Center, Multi-arm Phase Ib Study, Kyaw Z Thein, Daniel D Karp, Apostolia Tsimberidou, et al.
Correction To: Selinexor in Combination With Carboplatin and Paclitaxel in Patients With Advanced Solid Tumors: Results of a Single-Center, Multi-Arm Phase Ib Study, Kyaw Z Thein, Daniel D Karp, Apostolia Tsimberidou, et al.